492 related articles for article (PubMed ID: 32867043)
1. Challenges and Opportunities in Clinical Applications of Blood-Based Proteomics in Cancer.
Bhawal R; Oberg AL; Zhang S; Kohli M
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32867043
[TBL] [Abstract][Full Text] [Related]
2. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
3. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.
Qian WJ; Jacobs JM; Liu T; Camp DG; Smith RD
Mol Cell Proteomics; 2006 Oct; 5(10):1727-44. PubMed ID: 16887931
[TBL] [Abstract][Full Text] [Related]
4. Application of Proteomics in Lung Research.
Reisdorph NA; Michel C; Fritz K; Reisdorph R
Methods Mol Biol; 2018; 1809():237-262. PubMed ID: 29987793
[TBL] [Abstract][Full Text] [Related]
5. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers: mining the biofluid proteome.
Veenstra TD; Conrads TP; Hood BL; Avellino AM; Ellenbogen RG; Morrison RS
Mol Cell Proteomics; 2005 Apr; 4(4):409-18. PubMed ID: 15684407
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq.
Zhang F; Deng CK; Wang M; Deng B; Barber R; Huang G
BMC Bioinformatics; 2020 Dec; 21(Suppl 9):541. PubMed ID: 33272210
[TBL] [Abstract][Full Text] [Related]
8. Approaching clinical proteomics: current state and future fields of application in fluid proteomics.
Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tarnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Verhuven W; Wagener C; Wagner O; Schmitz G
Clin Chem Lab Med; 2009; 47(6):724-44. PubMed ID: 19527139
[TBL] [Abstract][Full Text] [Related]
9. High-throughput and targeted in-depth mass spectrometry-based approaches for biofluid profiling and biomarker discovery.
Jimenez CR; Piersma S; Pham TV
Biomark Med; 2007 Dec; 1(4):541-65. PubMed ID: 20477373
[TBL] [Abstract][Full Text] [Related]
10. Mining the acidic serum proteome utilizing off-gel isoelectric focusing and label free quantitative liquid chromatography mass spectrometry.
Smith J; Davey G; Polom K; Roviello F; Bones J
J Chromatogr A; 2018 Sep; 1566():32-43. PubMed ID: 29945787
[TBL] [Abstract][Full Text] [Related]
11. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
[TBL] [Abstract][Full Text] [Related]
12. Direct Assessment of Plasma/Serum Sample Quality for Proteomics Biomarker Investigation.
Greco V; Piras C; Pieroni L; Urbani A
Methods Mol Biol; 2017; 1619():3-21. PubMed ID: 28674873
[TBL] [Abstract][Full Text] [Related]
13. Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma.
Reale A; Khong T; Xu R; Chen M; Mithraprabhu S; Bingham N; Spencer A; Greening DW
Methods Mol Biol; 2021; 2261():151-191. PubMed ID: 33420989
[TBL] [Abstract][Full Text] [Related]
14. Plasma/Serum Proteomics based on Mass Spectrometry.
Zhu Y
Protein Pept Lett; 2024; 31(3):192-208. PubMed ID: 38869039
[TBL] [Abstract][Full Text] [Related]
15. Urine Proteomics in the Era of Mass Spectrometry.
Beasley-Green A
Int Neurourol J; 2016 Nov; 20(Suppl 2):S70-75. PubMed ID: 27915473
[TBL] [Abstract][Full Text] [Related]
16. Mass Spectrometry-Based Plasma Proteomics: Considerations from Sample Collection to Achieving Translational Data.
Ignjatovic V; Geyer PE; Palaniappan KK; Chaaban JE; Omenn GS; Baker MS; Deutsch EW; Schwenk JM
J Proteome Res; 2019 Dec; 18(12):4085-4097. PubMed ID: 31573204
[TBL] [Abstract][Full Text] [Related]
17. Secretome Proteomic Approaches for Biomarker Discovery: An Update on Colorectal Cancer.
Cevenini A; Orrù S; Imperlini E
Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32878319
[TBL] [Abstract][Full Text] [Related]
18. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
Núñez Galindo A; Macron C; Cominetti O; Dayon L
Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
[TBL] [Abstract][Full Text] [Related]
19. Mass Spectrometry-Based Serum Proteomics for Biomarker Discovery and Validation.
Bhosale SD; Moulder R; Kouvonen P; Lahesmaa R; Goodlett DR
Methods Mol Biol; 2017; 1619():451-466. PubMed ID: 28674903
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
